Recent developments in the pathogenesis of rheumatoid arthritis focusing on the role of synovial fibroblasts;Die Rheumatoide Arthritis: Neuentwicklungen in der Pathogenese unter besonderer Berücksichtigung der synovialen Fibroblasten

Zeitschrift fur Rheumatologie

Volumn 60, Issue 5, 2001, Pages 309-318

  Seemayer, C A ^a   Distler, O ^a   Kuchen, S ^a   Muller Ladner U ^b   Michel, B A ^a   Neidhart, M ^a   Gay, R E ^a   Gay, S ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA1 INTEGRIN; HOMING RECEPTOR; INTEGRIN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICULAR CARTILAGE; FIBROBLAST; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOLOGY; PHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM;

ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; ENGLISH ABSTRACT; FIBROBLASTS; HUMAN; INTEGRIN ALPHA4BETA1; INTEGRINS; INTERLEUKIN-1; LYMPHOCYTE ACTIVATION; RECEPTORS, LYMPHOCYTE HOMING; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0035491691     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930170030     Document Type: Article

References (67)

1. Aicher WK, Heer AH, Trabandt A, Bridges SL, Schroeder HW, Stransky G, Gay RE, Eibel H, Peter HH, Siebenlist U, Koopmann WJ, Gay S (1994) Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. J Immunol 153:5340-5348
2. Bishop JM (1985) Viruses, genes, and cancer. II. Retroviruses and cancer genes. Cancer 55:2329-2333
3. Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljan Z, Emery P, Nuki G, Pavelka K, Rau R, Rozman B, Watt I, Williams B, Aitchison R, McCabe D, Musikic P (1998) Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41:2196-2204
4. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR (1994) Osteopontin expression and distribution in human carcinomas. Am J Pathol 145:610-623
5. Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, Constantin A, Laroche M, Mazieres B (1999) Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 42:1093-1100
6. Chen E, Keystone EC, Fish EN (1993) Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 36:901-910
7. Craig AM, Bowden GT, Chambers AF, Spearman MA, Greenberg AH, Wright JA, McLeod M, Denhardt DT (1990) Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Int J Cancer 46:133-137
8. S. Cunnane G, FitzGerald O, Hummel KM, Gay RE, Gay S, Bresnihan B (1999) Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology (Oxford) 38:34-42
9. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-1330
10. Firestein GS, Paine MM (1992) Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. Am J Pathol 140:1309-1314
11. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ (1996) Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 149:2143-2151
12. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR (1997) Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 94:10895-10900
13. Firestein GS, Zvaifler NJ (1990) How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33:768-773
14. Franz JK, Pap T, Müller-Ladner U, Gay RE, Burmester GR, Gay S (1998) T cell-independent joint destruction. T Cells in Arthritis. In: Miossec P, van den Berg WB, Firestein GS (eds) Birkhäuser Verlag, Basel/Switzerland, pp 55-74
15. Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, Müller-Ladner U, Gay RE, Gay S (2000) Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 43:599-607
16. Gay S, Gay RE, Koopman WJ (1993) Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 52(suppl 1):S39-S47
17. Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH (1991) In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 34:1076-1084
18. Grewal IS, Flavell RA (1998) CD40 and GD154 in cell-mediated immunity. Annu Rev Immunol 16:111-135
19. Herrmann M, Neidhart M, Gay S, Hagenhofer M, Kalden JR (1998) Retrovirus-associated rheumatic syndromes. Curr Opin Rheumatol 10:347-354
20. Hummel KM, Petrow PK, Franz JK, Müller-Ladner U, Aicher WK, Gay RE, Brömme D, Gay S (1998) Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 25:1887-1894
21. Keyszer G, Redlich A, Häupl T, Zacher J, Sparmann M, Ungethüm U, Gay S, Burmester GR (1998) Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. Arthritis Rheum 41:1378-1387
22. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D (1995) Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917-4925
23. Kikuchi H, Shimada W, Nonaka T, Ueshima S, Tanaka S (1996) Significance of serine proteinase and matrix metalloproteinase systems in the destruction of human articular cartilage. Clin Exp Pharmacol Physiol 23:885-889
24. Koch AE (2000) The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 59(suppl 1):65-71
25. Konttinen YT, Nykanen P, Nordstrom D, Saari H, Sandelin J, Santavirta S, Kouri T (1989) DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study. J Rheumatol 16:339-345
26. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, Kinne RW, Santavirta S, Sorsa T, Lopez-Otin C, Takagi M (1999) Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58:691-697
27. Konttinen YT, Salo T, Hanemaaijer R, Valleala H, Sorsa T, Sutinen M, Ceponis A, Xu JW, Santavirta S, Teronen O, Lopez-Otin C (1999) Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol 18:401-412
28. Kriegsmann J, Keyszer GM, Geiler T, Bräuer R, Gay RE, Gay S (1995) Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 72:209-214
29. Kullmann F, Judex M, Neudecker I, Lechner S, Jüsten HP, Green DR, Wessinghage D, Firestein GS, Gay S, Scholmerich J, Müller-Ladner U (1999) Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 42:1594-1600
30. Kyburz D, Corr M, Brinson DC, Von Damm A, Tighe H, Carson DA (1999) Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J Immunol 163:3116-3122
31. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL (1989) Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 83:1267-1276
32. Lee CS, Portek I, Edmonds J, Kirkham B (2000) Synovial membrane p53 protein immunoreactivity in rheumatoid arthritis patients. Ann Rheum Dis 59:143-145
33. MacDonald KP, Nishioka Y, Lipsky PE, Thomas R (1997) Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 100:2404-2414
34. Matsumoto S, Müller-Ladner U, Gay RE, Nishioka K, Gay S (1996) Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 23:1345-1352
35. Mauri C, Mars LT, Londei M (2000) Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process. Nat Med 6:673-679
36. May P, May E (2000) Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 19:1734
37. Melter M, Reinders ME, Sho M, Pal S, Geehan C, Denton MD, Mukhopadhyay D, Briscoe DM (2000) Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96:3801-3808
38. Mohr W, Hummler N, Pelster B, Wessinghage D (1986) Proliferation of pannus tissue cells in rheumatoid arthritis. Rheumatol Int 6:127-132
39. Müller-Ladner U, Kriegsmann J, Gay RE, Gay S (1995) Oncogenes in rheumatoid arthritis. Rheum Dis Clin NAm 21:675-690
40. Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149:1607-1615
41. Müller-Ladner U, Elices MJ, Kriegsmann JB, Strahl D, Gay RE, Firestein GS, Gay S (1997) Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium. J Rheumatol 24:1873-1880
42. Müller-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans CH, Gay S (1997) Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol 158:3492-3498
43. Müller-Ladner U, Gay RE, Gay S (1998) Retroviral sequences in rheumatoid arthritis synovium. Int Rev Immunol 17:273-290
44. Müller-Ladner U, Evans CH, Franklin BN, Roberts CR, Gay RE, Robbins PD, Gay S (1999) Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum 42:490-497
45. Neidhart M, Rethage J, Kuchen S, Kunzler P, Crowl RM, Billingham ME, Gay RE, Gay S (2000) Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum 43:634-647
46. Neidhart M, Gay RE, Gay S (2000) Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 43:1719-1728
47. Neidhart M, Wehrli R, Brühlmann P, Michel BA, Gay RE, Gay S (1999) Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Arthritis Rheum 42:622-630
48. Neumann E, Judex M, Pap T, Distler O, Gay RE, Robbins PD, Evans CH, Scholmerich J, Gay S, Müller-Ladner U (2000) Additive cartilage protection by retrovirus-based double gene transfer with IL-1ra and IL-10 in the SCID mouse model for RA. Arthritis Rheum 43:5170 (abstract)
49. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H (1989) Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 48:645-653
50. Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S (1999) Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2:59-64
51. Pap T, Shigeyama Y, Kuchen S, Fernihough JK, Simmen B, Gay RE, Billingham M, Gay S (2000) Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 43:1226-1232
52. Perlman H, Georganas C, Pagliari LJ, Koch AE, Haines K 3rd, Pope RM (2000) Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 164:5227-5235
53. Perlman H, Pagliari LJ, Liu H, Koch AE, Haines GK 3rd, Pope RM (2001) Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum 44:21-30
54. Petrow PK, Hummel KM, Schedel J, Franz JK, Klein CL, Müller-Ladner U, Kriegsmann J, Chang PL, Prince CW, Gay RE, Gay S (2000) Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum 43:1597-1605
55. Rinaldi N, Barth T, Henne C, Mechtersheimer G, Möller P (1994) Synoviocytes in chronic synovitis in situ and cytokine stimulated synovial cells in vitro neo-express alpha 1, alpha 3 and alpha 5 chains of beta 1 integrins. Virchows Arch 425:171-180
56. Rinaldi N, Schwarz-Eywiil M, Weis D, Leppelmann-Jansen P, Lukoschek M, Keilholz U, Barth TF (1997) Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis 56:45-51
57. Schedel J, Gay RE, Simmen B, Gay S (2000) Flice-inhibitory protein (FLIP) expression at sites of cartilage and bone destruction in rheumatoid arthritis (RA). Arthritis Rheum 43:S160 (abstract)
58. Sorsa T, Konttinen YT, Lindy O, Ritchlin C, Saari H, Suomalainen K, Eklund KK, Santavirta S (1992) Collagenase in synovitis of rheumatoid arthritis. Semin Arthritis Rheum 22:44-53
59. Shigeyama Y, Pap T, Künzler P, Simmen BR, Gay RE, Gay S (2000) Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum 43:2523-2530
60. Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K (1996) Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 55:442-449
61. van der Laan WH, Pap T, Ronday HK, Grimbergen JM, Huisman LG, TeKoppele JM, Breedveld FC, Gay RE, Gay S, Huizinga TW, Verheijen JH, Quax PH (2000) Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor. Arthritis Rheum 43:1710-1718
62. Varmus HE (1985) Viruses, genes, and cancer. I. The discovery of cellular oncogenes and their role in neoplasia. Cancer 15:2324-2328
63. Wahl SM, Allen JB, Hines KL, Imamichi T, Wahl AM, Furcht LT, McCarthy JB (1994) Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 94(2):655-662
64. Wendling D, Racadot E, Wijdenes J, Sibilia J, Flipo RM, Cantagrel A, Miossec P, Eschard JP, Macro M, Bertin P, Liote F, Debiais F, Juvin R, Le Goff P, Massen C (1998) A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis. J Rheumatol 25:1457-1461
65. Westhoff CS, Freudiger D, Petrow P, Seyfert C, Zacher J, Kriegsmann J, Pap T, Gay S, Stiehl P, Gromnica-Ihle E, Wernicke D (1999) Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum 42:1517-1527
66. Weyand CM (2000) New insights into the pathogenesis of rheumatoid arthritis. Rheumatology 39(suppl 1):3-8
67. Yamanaka H, Makino K, Takizawa M, Nakamura H, Fujimoto N, Moriya H, Nemori R, Sato H, Seiki M, Okada Y (2000) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium. Lab Invest 80:677-687